IRIS Accounts Production v24.2.0.383 13821661 director 1.1.23 31.12.23 31.12.23 false true false false false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh138216612022-12-31138216612023-12-31138216612023-01-012023-12-31138216612021-12-29138216612021-12-302022-12-31138216612022-12-3113821661ns15:EnglandWales2023-01-012023-12-3113821661ns14:PoundSterling2023-01-012023-12-3113821661ns10:Director12023-01-012023-12-3113821661ns10:PrivateLimitedCompanyLtd2023-01-012023-12-3113821661ns10:Micro-entities2023-01-012023-12-3113821661ns10:AuditExempt-NoAccountantsReport2023-01-012023-12-3113821661ns10:FullAccounts2023-01-012023-12-3113821661ns5:CurrentFinancialInstruments2023-12-3113821661ns5:CurrentFinancialInstruments2022-12-3113821661ns10:RegisteredOffice2023-01-012023-12-31138216611ns10:Director12022-12-31138216611ns10:Director12021-12-29138216611ns10:Director12023-01-012023-12-31138216611ns10:Director12021-12-302022-12-31138216611ns10:Director12023-12-31138216611ns10:Director12022-12-31
REGISTERED NUMBER: 13821661 (England and Wales)







UNAUDITED FINANCIAL STATEMENTS

FOR THE YEAR ENDED 31 DECEMBER 2023

FOR

ADHD SPECIALIST LIMITED

ADHD SPECIALIST LIMITED (REGISTERED NUMBER: 13821661)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2023




Page

Balance Sheet 1


ADHD SPECIALIST LIMITED (REGISTERED NUMBER: 13821661)

BALANCE SHEET
31 DECEMBER 2023

2023 2022
£    £    £    £   
FIXED ASSETS 23,072 21,392

CURRENT ASSETS 117,012 164,228

CREDITORS
Amounts falling due within one year (14,215 ) (37,494 )
NET CURRENT ASSETS 102,797 126,734
TOTAL ASSETS LESS CURRENT
LIABILITIES

125,869

148,126

CAPITAL AND RESERVES 125,869 148,126

NOTES TO THE FINANCIAL STATEMENTS

1. STATUTORY INFORMATION

ADHD Specialist Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address are as below:

Registered number: 13821661

Registered office: Rex Buildings
Alderley Road
Wilmslow
Cheshire
SK9 1HY

2. AVERAGE NUMBER OF EMPLOYEES

The average number of employees during the year was 2 (2022 - 2 ) .

ADHD SPECIALIST LIMITED (REGISTERED NUMBER: 13821661)

BALANCE SHEET - continued
31 DECEMBER 2023

NOTES TO THE FINANCIAL STATEMENTS

3. DIRECTOR'S ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to a director subsisted during the year ended 31 December 2023 and the period ended 31 December 2022:

2023 2022
£    £   
Dr S Ivantu
Balance outstanding at start of year (5,238 ) -
Amounts advanced 55,729 7,315
Amounts repaid (49,683 ) (12,553 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 808 (5,238 )

The balance outstanding as at 31 December 2023 was repaid within 9 months of the year end. Interest has been charged at the HMRC rate.



The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2023 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges his responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

ADHD SPECIALIST LIMITED (REGISTERED NUMBER: 13821661)

BALANCE SHEET - continued
31 DECEMBER 2023


The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the director and authorised for issue on 9 September 2024 and were signed by:





Dr S Ivantu - Director